• ChemBase ID: 1174
• Molecular Formular: C8H7O3S-
• Molecular Mass: 183.20438
• Monoisotopic Mass: 183.01159008
• SMILES: S(=O)(=O)([O-])c1ccc(cc1)C(*)C*
• Canonical SMILES: *CC(c1ccc(cc1)S(=O)(=O)[O-])*
• InChI: InChI=

NAMES AND DATABASE IDS

Names

• Brand Name: Kionex; Kayexalate
• Synonyms: SPS; Sodium polystyrene sulfonate; Polystyrene sulfonic acid; Sodium polystyrene sulfonic acid; Polystyrene sulfonate

Database IDs

• CAS Number: 28210-41-5
• PubChem SID: 46507832; 160964637
• PubChem CID: 0; 169893

CALCULATED PROPERTIES

• Log P: 2.05
• LOG S: -3.0
• Solubility (Water): 2.59e-01 g/l

DETAILS

DrugBank - DB01344

• Drug Groups: approved
• Description: Sodium polystyrene sulfonate is a medication used to treat abnormally high potassium levels. It may be taken orally or by rectum, as an enema, and functions as a potassium-binding resin in the intestines. It is also an effective topical microbicide and spermicide, inhibiting the genital transfection of, among others, HIV. [Wikipedia]
• Indication: Used to treat abnormally high potassium levels.
• Pharmacology: Polystyrene sulfonate affects the exchange of sodium and potassium in the body. Polystyrene sulfonate is used to treat high levels of potassium in the blood, also called hyperkalemia. It is a potassium-binding ion-exchange resin that can be administered orally (25 grams in 20% sorbitol) or rectally (50 grams in 20% sorbitol).
• Toxicity: Overdose symptoms may include confusion, irritability, trouble thinking or concentrating, muscle weakness, or trouble breathing.
• Affected Organisms: Humans and other mammals
• Biotransformation: none
• Absorption: Not absorbed following oral administration.
• Half Life: none
• Elimination: Feces.
• External Links: Wikipedia